Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Multiple Myeloma
Interventions
DRUG

Daratumumab

Daratumumab will be administered via a subcutaneous injection (SC)

DRUG

Bortezomib

Bortezomib will be administered via a subcutaneous injection (SC)

DRUG

Lenalidomide

Lenalidomide will be administered orally

DRUG

Dexamethasone

Dexamethasone will be administered orally

Trial Locations (31)

10126

RECRUITING

A.O.U. Città della Salute e della Scienza di Torino - SC Ematologia U, Torino

Unknown

NOT_YET_RECRUITING

Innsbruck Medical University, Innsbruck

RECRUITING

Ordensklinikum Linz, Linz

NOT_YET_RECRUITING

Clinic Ottakring, Vienna

NOT_YET_RECRUITING

Medical University of Vienna, Vienna

RECRUITING

Universitätsklinikum Hamburg - Eppendorf, Hamburg

NOT_YET_RECRUITING

Klinikum rechts der Isar (MRI) der Technischen Universität München Department of Internal Medicine III (Hematology/Oncology) Munchen, München

RECRUITING

University Hospital of Alexandroupolis, Alexandroupoli

RECRUITING

Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens, Athens

RECRUITING

St Savvas Cancer Hospital, Athens

RECRUITING

Theagenion Cancer Hospital, Thessaloniki

RECRUITING

AOU Ospedali Riuniti di Ancona, Ancona

RECRUITING

ASST Papa Giovanni XXIII Hospital, Bergamo

NOT_YET_RECRUITING

A.O.U. di Bologna - Policlinico S. Orsola Malpighi, Bologna

RECRUITING

A.O.Spedali Civili di Brescia, Brescia

RECRUITING

A.O.U. Careggi - Firenze, Florence

NOT_YET_RECRUITING

A.O.U. Policlinico S. Martino - Ematologia, Genova

RECRUITING

Novara Hospital, Novara

RECRUITING

Policlinico S. Matteo Fondazione IRCCS - Pavia, Pavia

RECRUITING

AUSL-IRCCS di Reggio Emilia Arcispedale S. Maria Nuova, Reggio Emilia

RECRUITING

"Ospedale Infermi di Rimini", Rimini

RECRUITING

Ematologia IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, San Giovanni Rotondo

NOT_YET_RECRUITING

A.O. S. Santa Maria Hospital Institute of Oncohematology Terni, Terni

NOT_YET_RECRUITING

Ospedale S. Maria della Misericordia di Udine, Udine

NOT_YET_RECRUITING

Amsterdam Medical Center, Amsterdam

RECRUITING

Rijnstate, Arnhem

NOT_YET_RECRUITING

Amphia ziekenhuis, Breda

NOT_YET_RECRUITING

University Medical Center Groningen, Groningen

RECRUITING

Dijklander ziekenhuis, Purmerend

NOT_YET_RECRUITING

Erasmus University Medical Center Rotterdam, Rotterdam

RECRUITING

Maasstad Ziekenhuis, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen Pharmaceutica

INDUSTRY

lead

Stichting European Myeloma Network

NETWORK

NCT06189833 - Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS | Biotech Hunter | Biotech Hunter